IBD

Clinical trials for IBD explained in plain language.

Never miss a new study

Get alerted when new IBD trials appear

Sign up with your email to follow new studies for IBD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 3 Completed 1 Terminated 1

Crohn's drug study cut short: only 18 patients enrolled

Disease control Terminated

This study looked at the long-term safety of the drug brazikumab for people with moderate to severe Crohn's disease. It was designed for patients who had already completed or left an earlier study of the same drug. The study was terminated early and only enrolled 18 participants,…

Matched conditions: IBD

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 24, 2026 16:07 UTC

IBD

Get alerted when new IBD trials appear

Crohn's drug study cut short: only 18 patients enrolled